Introducing cell-free DNA noninvasive testing in a Down syndrome public health screening program: a budget impact analysis

BACKGROUND: Non-invasive prenatal testing (NIPT) using cell-free fetal DNA in maternal plasma is a high accurate test for prenatal screening for Down syndrome. Although it has been reported to be cost effective as a contingent test, evidence about its budget impact is lacking. OBJECTIVE: To evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Nshimyumukiza, L., Beaumont, J. A., Rousseau, F., Reinharz, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640422/
https://www.ncbi.nlm.nih.gov/pubmed/33292318
http://dx.doi.org/10.1186/s12962-020-00245-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640422/
https://www.ncbi.nlm.nih.gov/pubmed/33292318
http://dx.doi.org/10.1186/s12962-020-00245-5

Ejemplares similares